跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,050 条关于
“MeiraGTX Holdings”
全部
1,050
临床试验
85
药物
74
机构
153
资讯
738
去年
MeiraGTx's AAV2-hAQP1 Receives FDA RMAT Designation for Radiation-Induced Xerostomia
去年
MeiraGTx's AAV-GAD Gene Therapy Shows Promise in Parkinson's Disease Phase I/II Trial
去年
MeiraGTX's Gene Therapy Shows Promising Visual Benefits in Children with Rare Genetic Blindness
7个月前
ZipBio and MeiraGTx Partner to Develop AI-Designed Gene Therapy for Geographic Atrophy
去年
MeiraGTx Advances Gene Therapy Pipeline with FDA RMAT Designation and Pivotal Trial Progress
5个月前
MeiraGTx Receives FDA Breakthrough Therapy Designation for Gene Therapy Treating Radiation-Induced Dry Mouth
去年
CRUK Receives $225 Million Investment; New CAR-T Cell Facility; Promising Gene Therapy for Parkinson's
去年
MeiraGTx and Hologen AI Form $430 Million Strategic Collaboration to Advance Parkinson's Disease Gene Therapy
去年
MeiraGTx Unveils Breakthrough Gene Therapies for Obesity and Neurodegenerative Diseases at ASGCT 2025
5个月前
MeiraGTx Reacquires Gene Therapy Botaretigene Sparoparvovec from Johnson & Johnson for X-linked Retinitis Pigmentosa Treatment
第 1 页,共 74 页
上一页
下一页